Patent & IP news for October 3, 2010

Make money from IP? Not this way! from ipfinance.blogspot.com

Yesterday night marked the close of the IP Finance "IP begging letter competition", for which the prize was complimentary admission to CLT's IP and Finance Conference on 20 October.  To everyone's disappointment the ...

Share via E–mail | Twitter | Facebook

Letter from AmeriKat: Express's plaid pain in summary judgment for Forever 21 from ipkitten.blogspot.com

The AmeriKat is experiencing a mean blend of jet-lag and sleeplessness which is resulting in bouts of highly productive activities at odd hours in the morning. As a result, she has a little tail to ...

Share via E–mail | Twitter | Facebook

Ordinary & Extreme from www.patenthawk.com

The childishness of corporations is no better illustrated than in patent litigation, where, instead of coming to cross-license, the little boys fight it out in court. For their fat fees, lawyers egg this sort of ...

Share via E–mail | Twitter | Facebook

CBS Sunday Morning on October 3, 2010 from ipbiz.blogspot.com

Charles Osgood started with the suicide of Tyler Climenti of Rutgers. Jim Axelrod did the story which noted that suicide is the third leading killer of youth (Befoe their time). Anthony Mason does Coming Together ...

Share via E–mail | Twitter | Facebook

IPSCs and the stem cell patent landscape from ipbiz.blogspot.com

Patent Docs notes Sunlight Research will be offering a webinar entitled "How Are iPSCs Changing the Stem Cell Patent Landscape?on October 6, 2010 from 12:00 - 12:50 PM (EST). Dr. Robin Chadwick of ...

Share via E–mail | Twitter | Facebook

An Earnest call for responsible reporting from spicyipindia.blogspot.com

The Hindustan Times (HT), quoting the joint report issued by the World Health Organisation, UNAIDS, and UNICEF, reports that over one million HIV/AIDS patients in India do not have access to anti-retroviral (ARV) treatment ...

Share via E–mail | Twitter | Facebook

Yeda Appeals Board Decision Favoring Abbott in TBP-II Interference from holmansbiotechipblog.blogspot.com

Abbott and the Yeda Research and Development Co. have been involved in a patent interference since 1996 over the right to patent TNF-alpha Binding Protein II (TBP-II, also known as TNF receptor 2). This is ...

Share via E–mail | Twitter | Facebook

Happy birthday to me from ipwars.com

well, IPwars really.

Yes, six years ago today IPwars started rearranging electrons in the interstices of the interwebs (as some of our American cousins call them).

It’s rather hard to work out vital statistics ...

Share via E–mail | Twitter | Facebook

Federal Circuit two separate elements from allthingspros.blogspot.com

A new post "Two Separate Things Are Not One Thing" on the American IPA blog points out
that this summer's Becton opinion from the Federal Circuit includes a great quote for patent prosecutors:

Where ...

Share via E–mail | Twitter | Facebook

Conference & CLE Calendar from www.patentdocs.org

October 4, 2010 - Technology Transfer Symposium (Biotechnology Industry Organization) - San Francisco, CA October 4-5, 2010 - Patent Litigation 2010 (Practising Law Institute) - McLean, VA October 5-7, 2010 - 7th Annual Biosimilars Conference (Visiongain) - London, UK October 6 ...

Share via E–mail | Twitter | Facebook

Court Report from www.patentdocs.org

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Hospira, Inc. v. Eli Lilly & Co. 1:10-cv-06275; filed September 30, 2010 in the Northern District ...

Share via E–mail | Twitter | Facebook

Mark Lemley Part 2: In re Cipro, Patent Misuse, Fun Stuff from ipwatchdog.com

In part 1 of my interview with Mark Lemley we discussed whether the Supreme Court will take the i4i v. Microsoft case and address the presumption of validity, as well as what implications such a ...

Share via E–mail | Twitter | Facebook